Go to Page # Page of 7
loading

Hepatocellular Carcinoma HCC Treatment Market to Make Great Impact In Near Future by 2026

 Yogesh Sengar
  15th-Apr-2016
Description: Hepatocellular carcinoma (HCC) is also known as malignant hepatoma. HCC is the major malignancy of the liver and is found to occur mainly in patients with chronic liver diseases and cirrhosis. The cells of origin of HCC are the hepatic stem cells, although this remains the subject of investigation. The hepatic tumors proliferates with local expansion, spreading in intrahepatic region and finally distant metastases. The uncommon hepatocellular carcinoma is anticipated to witness rise in incidence rate during the forecast period. HCC is currently expected to be the third leading cause of death worldwide. In the past, HCC generally occurred at an advanced stage of decompensated liver disease or cirrhosis. The technological advancements and the routine liver function tests are now resulting in the early detection of hepatocellular carcinoma. The increase in incidences of hepatocellular carcinoma associated with hepatitis C virus are expected to grow the hepatocellular carcinoma treatment market during the forecast period.
Views: 176
Domain: Medical
Category: Biotech/Pharma
Contents:
Hepatocellular
Carcinoma (HCC)
Treatment Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016

Future Market Insights

www.futuremarketinsights.com

sales@futuremarketinsights.com

Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged sol ... See more
Yogesh Sengar
10 January, 2017
Yogesh Sengar
10 January, 2017
Yogesh Sengar
26 December, 2016